USANA Health Sciences, Inc. (NYSE:USNA) Short Interest Update

USANA Health Sciences, Inc. (NYSE:USNA) was the target of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 578,100 shares, an increase of 19.0% from the January 15th total of 485,900 shares. Approximately 5.2% of the shares of the stock are sold short. Based on an average trading volume of 113,600 shares, the short-interest ratio is presently 5.1 days.

Institutional Trading of USANA Health Sciences

Hedge funds have recently added to or reduced their stakes in the business. R Squared Ltd acquired a new stake in USANA Health Sciences in the 4th quarter worth about $28,000. Safe Harbor Fiduciary LLC acquired a new position in shares of USANA Health Sciences in the 3rd quarter valued at about $30,000. KBC Group NV lifted its stake in shares of USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after purchasing an additional 519 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of USANA Health Sciences in the 4th quarter valued at about $83,000. Finally, Quantbot Technologies LP acquired a new position in shares of USANA Health Sciences in the 4th quarter valued at about $132,000. 54.25% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

USNA has been the topic of a number of analyst reports. StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday. DA Davidson raised their price target on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research note on Thursday, January 2nd.

USANA Health Sciences Price Performance

NYSE:USNA traded up $0.13 during mid-day trading on Monday, reaching $31.73. The company’s stock had a trading volume of 134,987 shares, compared to its average volume of 123,145. The company’s fifty day simple moving average is $34.42 and its two-hundred day simple moving average is $37.06. USANA Health Sciences has a twelve month low of $30.13 and a twelve month high of $50.49. The stock has a market cap of $604.74 million, a P/E ratio of 11.21, a P/E/G ratio of 0.84 and a beta of 0.87.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.